114 related articles for article (PubMed ID: 430057)
1. Ganglioside-composition of brain in Tay-Sachs disease: increased amounts of GD2 and N-acetyl-beta-D-galactosaminyl GD1a ganglioside.
Iwamori M; Nagai Y
J Neurochem; 1979 Mar; 32(3):767-77. PubMed ID: 430057
[No Abstract] [Full Text] [Related]
2. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease?
Rosengren B; Månsson JE; Svennerholm L
J Neurochem; 1987 Sep; 49(3):834-40. PubMed ID: 3612128
[TBL] [Abstract][Full Text] [Related]
3. Characterization of some minor gangliosides in Tay-Sachs brains.
Yu RK; Itoh T; Yohe HC; Macala LJ
Brain Res; 1983 Sep; 275(1):47-52. PubMed ID: 6414648
[No Abstract] [Full Text] [Related]
4. Brain gangliosides: an improved simple method for their extraction and identification.
Randell JA; Pennock CA
J Chromatogr; 1980 Jul; 195(2):257-64. PubMed ID: 6773970
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of a novel monosialosylpentahexosyl ceramide from Tay-Sachs brain.
Itoh T; Li YT; Li SC; Yu RK
J Biol Chem; 1981 Jan; 256(1):165-9. PubMed ID: 7451432
[TBL] [Abstract][Full Text] [Related]
6. Identification of the accumulated ganglioside.
Svennerholm L
Adv Genet; 2001; 44():33-41. PubMed ID: 11596994
[No Abstract] [Full Text] [Related]
7. Ganglioside accumulation in cultured skin fibroblasts from gangliosidosis patients.
Pullarkat RK; Reha H; Beratis NG
Biochem Biophys Res Commun; 1980 Jan; 92(1):149-54. PubMed ID: 7356448
[No Abstract] [Full Text] [Related]
8. Extraction and purification of gangliosides from plasma and fibroblasts before analysis by thin layer chromatography.
Leenders RG; de Jong JG; Wevers RA
Ann Clin Biochem; 1995 Jan; 32 ( Pt 1)():68-73. PubMed ID: 7762953
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of lysoganglioside lyso-GM2 (II3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain.
Neuenhofer S; Conzelmann E; Schwarzmann G; Egge H; Sandhoff K
Biol Chem Hoppe Seyler; 1986 Mar; 367(3):241-4. PubMed ID: 3707714
[TBL] [Abstract][Full Text] [Related]
10. Abnormal gangliosides in Tay-Sachs disease, Niemann-Pick's disease, and gargoylism.
Booth DA; Goodwin H; Cumings JN
J Lipid Res; 1966 May; 7(3):337-40. PubMed ID: 4959256
[TBL] [Abstract][Full Text] [Related]
11. The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.
Tallman JF; Johnson WG; Brady RO
J Clin Invest; 1972 Sep; 51(9):2339-45. PubMed ID: 4639018
[TBL] [Abstract][Full Text] [Related]
12. A differential scanning calorimetry study of the interaction of gangliosides with peanut lectin, serotonin and daunomycin.
Bach D; Sela BA
Biochim Biophys Acta; 1980 Feb; 596(2):186-91. PubMed ID: 7356996
[TBL] [Abstract][Full Text] [Related]
13. Brain ceramide hexosides in Tay-Sachs disease and generalized gangliosidosis (GM1-gangliosidosis).
Suzuki K; Chen GC
J Lipid Res; 1967 Mar; 8(2):105-13. PubMed ID: 14564716
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical demonstration of GM2-ganglioside in the central nervous system of a 19-week-old fetus of Tay-Sachs disease.
Taniike M; Inui K; Hirabayashi Y; Tsukamoto H; Nishimoto J; Midorikawa M; Okada S; Yabuuchi H
J Inherit Metab Dis; 1989; 12 Suppl 2():372-4. PubMed ID: 2512447
[No Abstract] [Full Text] [Related]
15. Characterization of neutral glycolipids in Tay-Sachs brain.
Inagawa A; Makita A; Gasa S; Arashima SI
J Neurochem; 1979 Jul; 33(1):369-75. PubMed ID: 458466
[No Abstract] [Full Text] [Related]
16. Gangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain.
Hoffman LM; Brooks SE; Stein MR; Adachi M; Schneck L
Metab Brain Dis; 1989 Jun; 4(2):87-93. PubMed ID: 2547146
[TBL] [Abstract][Full Text] [Related]
17. [On a component of the mixture of brain gangliosides, which is transferred to the Tay-Sachs ganglioside under the influence of neuraminidase].
Klenk E; Naoi M
Hoppe Seylers Z Physiol Chem; 1968 Mar; 349(3):288-92. PubMed ID: 4302220
[No Abstract] [Full Text] [Related]
18. Gangliosides containing glucosamine and galactosamine in transformed Tay-Sachs disease and normal human brain cell lines.
Schneck L; Hoffman LM; Brooks SE; Amsterdam D
J Neurol Sci; 1980 Feb; 45(1):123-8. PubMed ID: 6244370
[TBL] [Abstract][Full Text] [Related]
19. Periodate oxidation of glycolipids: a borohydride-periodate-Schiff method for ganglioside demonstration in tissue sections.
Buk SJ; High OB
Histochem J; 1986 May; 18(5):228-32. PubMed ID: 3091539
[TBL] [Abstract][Full Text] [Related]
20. Spinal ganglia and peripheral nerves from a patent with Tay-Sachs disease. Morphological and ganglioside studies.
Abe T; Ogawa K; Fuziwara H; Urayama K; Nagashima K
Acta Neuropathol; 1985; 66(3):239-44. PubMed ID: 2990149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
